Gingival hyperplasia induced by amlodipine in a patient with chronic periodontitis. Case presentation
Abstract
Introduction: numerous reports based on epidemiological studies have demonstrated the existence of a relationship between periodontal infections and systemic diseases, while increases in gingival hyperplasia associated with the use of calcium channel blockers are reported.
Objective: to present a case of gingival hyperplasia induced by amlodipine, which is of interest to health professionals because it is a rare entity in the stomatological practice and also is the least studied adverse effect of this drug.
Case presentation: female patient of 40 years of age and white skin color, who attended the Periodontal Consultation due to bleeding and severe inflammation of the gums, with discomfort when speaking and during chewing. The patient suffers high blood pressure and she was decompensated, so she had been treated with amlodipine at doses of 10 mg daily for four months. Physical and radiographic exams revealed a gingival hyperplasia associated with chronic, deep and generalized adult periodontitis, for which antimicrobial treatment was combined with aqueous chlorhexidine rinses, tartrectomy (manual and ultrasonic) and amlodipine replacement with atenolol. At two months of treatment, the symptoms went forward.
Conclusions: in patients with chronic periodontitis it is not recommended to use amlodipine to compensate the arterial hypertension, because induced gingival hyperplasia forms a vicious cycle with the underlying disease and aggravates it, which can lead to cardiovascular atherosclerotic disease.Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Yanara Álvarez Mirabal, Leidys Odelsa Martínez Carbonell
This work is licensed under a Creative Commons Attribution 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
